Pain Points and Potential: How COVID-19 is Reshaping Global Health R&D
Analysis of interviews with researchers and thought leaders on how COVID-19 is impacting R&D for neglected diseases and conditions, including lab-based research, clinical trials, funding, and global collaboration. It explores both immediate impacts as well as long-term trends and challenges that could reshape the sector in the coming years.